Asset Strategy and Investment /
Branding and Positioning /
Commercial Strategy /
Insight Generation /
Lifecycle Management /
Market Access Strategy /
Market Landscapes /
Patient Journeys /
Pricing /
Value Story Development /
Workshops and Brainstorming /
Case Study: Understanding the potential lifecycle for a broadly effective biologic
Problem
A leading pharmaceutical company, working with a biotech partner, wanted to create a long term Lifecycle Management program for a jointly developed biologic.
Solution
We evaluated 34 potential indications across respiratory, dermatology, ophthalmology, and other diseases. The project was conducted in stages:
- Interviews with key internal stakeholders (across disciplines) to ensure alignment on strategic intent between us and the client; and to rapidly build understanding of known market facts
- Desk research, internal data review and interviews, and 40 interviews with KOLs to narrow indications to 14, which were scored by scientific and commercial attractiveness on a proprietary Multi-Variable Analysis (MVA) engine
- Use of the MVA engine to identify 4 lead indications jointly with the client, then conducted another 8 KOL interviews, along with 13 payer interviews in the US, UK, France, and Germany to provide a comprehensive view and a path to market for each opportunity
Outcome
- An agreed upon view on leading potential opportunities, including potential market entry and lifecycle targets.
- Disease assessments on all 34 indications.
- A dynamic tool for assessing and visualizing opportunities as market factors change.